Cantrell Drug Looks For a Buyer, Again

Cantrell Drug Co. hopes its next potential buyer can close the deal to purchase the Little Rock drug compounding company out of Chapter 11 bankruptcy reorganization.

Want the Full Article?

Get Unlimited Archive Access for $19.95 per Year

Readers must pay to access articles older than 15 days.
Articles newer than 15 days are not included in this offer.

Purchase Now

Already have archive access? Login to view this article.